Amanta Healthcare Intrinsic Value
AMANTA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹101.20 | ₹80.96 - ₹121.44 | -7.0% | EPS: ₹4.60, Sector P/E: 22x |
| Book Value Method | asset | ₹66.21 | ₹59.59 - ₹72.83 | -39.2% | Book Value/Share: ₹33.10, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹191.72 | ₹172.55 - ₹210.89 | +76.2% | Revenue/Share: ₹95.86, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹204.31 | ₹183.88 - ₹224.74 | +87.8% | EBITDA: ₹61.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹189.25 | ₹151.40 - ₹227.10 | +73.9% | CF Growth: 11.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹32.64 | ₹29.38 - ₹35.90 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹70.79 | ₹63.71 - ₹77.87 | -34.9% | Revenue Growth: 5.2%, Adj P/E: 15.4x |
| ROE Based Valuation | profitability | ₹54.41 | ₹48.97 - ₹59.85 | -50.0% | ROE: 13.5%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹58.53 | ₹52.68 - ₹64.38 | -46.2% | EPS: ₹4.60, BVPS: ₹33.10 |
Want to compare with current market value? Check AMANTA share price latest .
Valuation Comparison Chart
AMANTA Intrinsic Value Analysis
What is the intrinsic value of AMANTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Amanta Healthcare (AMANTA) is ₹70.79 (median value). With the current market price of ₹108.81, this represents a -34.9% variance from our estimated fair value.
The valuation range spans from ₹32.64 to ₹204.31, indicating ₹32.64 - ₹204.31.
Is AMANTA undervalued or overvalued?
Based on our multi-method analysis, Amanta Healthcare (AMANTA) appears to be trading above calculated value by approximately 34.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.81 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 3.98 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 13.5% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.73x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Amanta Healthcare
Additional stock information and data for AMANTA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹47 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹58 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹40 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹62 Cr | ₹59 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹31 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |